Company / Tangible Book Value per Share
Amneal Pharmaceuticals, Inc. Tangible Book Value per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
-$3.78
FY2025
5-year range
-$4.68 / -$1.23
FY2021-FY2025
Trend
+19.2%
vs FY2024
Sector context
#199 of 209
Health Care
What the data says
Among 209 Health Care companies, Amneal Pharmaceuticals, Inc. is in the bottom 5% for tangible book value per share. Tangible Book Value per Share returned to growth in FY2025 after 4 years of decline, reaching $-3.78.
Based on SEC 10-K filings.
-3.78 in FY2025.
Remained stable around $-3.78 over the past 2 years.
Health Care sector context is included.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 5% in Health CareTop 95% of 209This company -$3.78 Sector average $93.47
▼
-104.0% below sector average
Key checks
Key Insights
- In FY2025, tangible book value per share increased 19.2% year-over-year.
- Ranks #199 out of 209 companies in the Health Care sector.
- Peak tangible book value per share was recorded in FY2018.
- Lowest tangible book value per share in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score 1.22 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$3.78 | +19.2% |
| FY2024 | -$4.68 | -22.7% |
| FY2023 | -$3.81 | -89.1% |
| FY2022 | -$2.02 | -64.0% |
| FY2021 | -$1.23 | -34.6% |
| FY2020 | -$0.91 | +40.2% |
| FY2019 | -$1.53 | -140.6% |
| FY2018 | $3.76 | +100.0% |
| FY2017 | -$26444.00 | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026